B-cells in pulmonary arterial hypertension: friend, foe or bystander?
B-cells are recruited to and activated in PAH lungs and contribute to vascular remodelling through production of autoantibodies targeting the lung vasculature and cytokines. B-cell targeted therapies are a promising direction for select PAH conditions. https://bit.ly/3T9mNde